CARIBOU BIOSCIENCES INC (CRBU) Stock Analyst Ratings
NASDAQ:CRBU - Nasdaq - US1420381089 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to CRBU. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 13.52. This target is 931.68% above the current price.
CRBU was analyzed by 15 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CRBU.
In the previous month the buy percentage consensus was at a similar level.
CRBU was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-07 | B of A Securities | Maintains | Buy -> Buy |
| 2024-11-26 | Citigroup | Maintains | Buy -> Buy |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-07 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-07-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-04 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-16 | Truist Securities | Maintains | Buy -> Buy |
| 2024-05-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-19 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-12 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-11-08 | Cantor Fitzgerald | Initiate | Neutral |
| 2023-07-26 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-07-14 | Truist Securities | Reiterate | Buy -> Buy |
| 2023-07-11 | Truist Securities | Initiate | Buy |
| 2023-05-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-03-14 | HC Wainwright & Co. | Maintains | Buy |
| 2023-03-10 | Oppenheimer | Maintains | Outperform |
| 2023-03-10 | RBC Capital | Reiterate | Outperform |
| 2022-08-29 | Citigroup | Maintains | Buy |
| 2022-08-18 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-10 | RBC Capital | Maintains | Outperform |
| 2022-05-13 | Citigroup | Maintains | Buy |
| 2022-05-12 | SVB Leerink | Maintains | Outperform |
| 2022-05-10 | SVB Leerink | Maintains | Outperform |
| 2022-02-18 | RBC Capital | Initiate | Outperform |
| 2022-02-14 | Brookline Capital | Initiate | Buy |
| 2021-12-01 | Oppenheimer | Initiate | Outperform |
| 2021-11-30 | HC Wainwright & Co. | Initiate | Buy |